• Select your country/language
  • New Zealand
  • Argentina
  • Australia
  • Belgique (Belgium) - Français
  • België (Belgium) – Nederlands
  • Brasil (Brazil)
  • Chile
  • Colombia
  • Danmark (Denmark)
  • Deutschland (Germany)
  • España (Spain)
  • France – Français
  • Italia (Italy)
  • Japan - 日本
  • Magyarország (Hungary)
  • México
  • Nederland (Netherlands)
  • Norge (Norway)
  • Panamá
  • Perú
  • Poland
  • Portugal
  • Puerto Rico
  • Schweiz (Switzerland) - Deutsch
  • South Africa
  • Suisse (Switzerland) – Français
  • Suomi (Finland)
  • Sverige (Sweden)
  • Svizzera (Switzerland) – Italiano
  • Türkiye (Turkey)
  • United Kingdom
  • Österreich (Austria)
  • Česká republika (Czech Republic)
  • Ελλάδα (Greece)
Medtronic logo
placeNew Zealand
Contact Us
  • Products
  • placeNew Zealand
Clear
SearchLoading
Cancel
Minimally Invasive Therapies / Products / Cerebral/Somatic Oximetry / INVOS™ Perspective / Resources

INVOS™ Perspective
  • Patient Outcomes
  • Resources

INVOS™ Resources

View Supporting Studies and Resources

  • Cerebral Oxygen Desaturation Predicts Cognitive Decline and Longer Hospital Stay After Cardiac Surgery
  • Optimising Intraoperative Cerebral Oxygen Delivery Using Non-invasive Cerebral Oximetry Decreases the Incidence of Stroke for Cardiac Surgical Patients
  • Monitoring Brain Oxygen Saturation During Coronary Bypass Surgery: A Randomised, Perspective Study

Explore INVOS™ Regional Oximetry

Learn more about INVOS™ cerebral/somatic oximetry.

About Medtronic
  • Medtronic Corporate ANZ
  • Privacy Statement
  • Terms of Use
  • Terms & Conditions of Supply
  • External Research Program
Minimally Invasive Therapies
  • Products
  • Terms & Conditions of Supply
  • Sitemap
  • Australia/New Zealand Customer Service
Contact Us
Country Office

Level 3 - Building 5

Central Corporate Centre

666 Great South Road

Penrose, Auckland

New Zealand

©2025 Medtronic